Clinical studies recruiting near Dordrecht

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Albert Schweitzer Ziekenhuis location Dordwijk · Amgen · NCT07037433 Anastomotic Leakage Prevention by Endovascular Stenting of the Superior Mesenteric Artery
NA · Albert Schweitzer ziekenhuis · Medisch Spectrum Twente · NCT07486570 Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer
Phase N/A · Albert Schweitzer Hospital · Maastricht University Medical Center · NCT04486495 Spinal Cord Monitoring in Multiple Sclerosis
Phase N/A · Albert Schweitzer ziekenhuis · Zuyderland Medisch Centrum · NCT06827834 Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
Phase 4 · Albert Schweitzer Ziekenhuis Dordrecht · Drahomir Aujesky · NCT04263038 Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment
Phase N/A · Albert Schweitzer Ziekenhuis · Catharina Ziekenhuis Eindhoven · NCT05405270 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Phase 3 · Albert Schweitzer Ziekenhuis, locatie Dordwijk · Eli Lilly and Company · NCT07223593 National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Phase N/A · Albert Schweitzer · PROspective Renal Cancer Cohort Foundation · NCT05326620 Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma
NA · Albert Schweitzer hospital · Erasmus Medical Center · NCT06643286 S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System
Phase N/A · Albert Schweitzer Ziekenhuis · Sahajanand Medical Technologies Limited · NCT03443999 A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Phase 2 · Albert Schweitzer Ziekenhuis · Janssen Research & Development, LLC · NCT06500884 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Albert SchweitzerZiekenhuis · Boehringer Ingelheim · NCT06632457 A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratum
Phase 3 · Albert Schweitzer Ziekenhuis, locatie Dordwijk · Pfizer · NCT05623020 Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Phase 3 · Albert Schweitzer Ziekenhuis · Italfarmaco · NCT06093672 A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compar
Phase 3 · Albert Schweitzer Ziekenhuis · BeOne Medicines · NCT06943872 Promoting Optimal Treatment Choices in Neonates With Suspected Early-Onset Sepsis
Phase N/A · Albert Schweitzer Ziekenhuis · Franciscus Gasthuis · NCT06845332 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Albert Schweitzer Ziekenhuis - Dordwijk · Mirati Therapeutics Inc. · NCT04613596 Prospective Bladder Cancer Infrastructure (ProBCI)
Phase N/A · Albert Schweitzer Hospital · Prospective Bladder Cancer Infrastructure Foundation · NCT04503577 REtreatment With VEnetoclax and Acalabrutinib After Venetoclax Limited Duration (REVEAL)
Phase 2 · NL-Dordrecht-ASZ · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT04523428 Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participa
Phase 3 · Albert Schweitzer Ziekenhuis, Locatie Dordwijk · Amgen · NCT06252649 Prospective Data Collection Initiative on Colorectal Cancer
Phase N/A · Albert Schweitzer Ziekenhuis · Dutch Colorectal Cancer Group · NCT02070146 LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.
Phase 3 · Albert Schweitzer Hospital · M. Medici · NCT05682482 MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · Albert Schweitzer Ziekenhuis, locatie Dordwijk · Pfizer · NCT06152575 Autonomous Blood Drawing Optimization and Performance Testing
NA · Result Laboratorium, location Albert Schweitzer Hospital · Vitestro B.V. · NCT05878483 FeAsiBility of a Treatment Free Interval in Newly Diagnosed MM Patients Treated With Daratumumab-lenalidomide-dexamethas
Phase 3 · NL-Dordrecht-ASZ · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT06187441 Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML
Phase 3 · NL-Dordrecht-ASZ · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT07075016 A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Pr
Phase 3 · Albert Schweitzer Ziekenhuis ( Site 2103) · Merck Sharp & Dohme LLC · NCT06717347 Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
Phase 3 · NL-Dordrecht-ASZ · Stichting Hemato-Oncologie voor Volwassenen Nederland · NCT06220032 A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone
Phase 3 · Albert Schweitzer Hospital · Regeneron Pharmaceuticals · NCT05730036 A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib
Phase 3 · Albert Schweitzer Ziekenhuis · BeOne Medicines · NCT07277231

Look up another city

Look up another condition